Portfolio company
Softhale
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops propellant-free soft mist inhaler devices and pharmaceutical products for patients suffering from asthma and chronic obstructive pulmonary disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
AirNexis Therapeutics
This company develops inhaled small molecule medicines to treat chronic obstructive pulmonary disease for patients with respiratory conditions.
AQUILON PHARMACEUTICALS
The company develops inhaled medicines and nasal sprays for patients with asthma, chronic obstructive pulmonary disease and other respiratory conditions.
Aer Therapeutics
This biopharmaceutical company develops inhaled mucolytic treatments for patients with muco-obstructive lung diseases, including chronic obstructive pulmonary disease and asthma.
Kinaset Therapeutics
This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.
Propeller
This company develops inhaler sensors and software to help patients and healthcare providers monitor and manage asthma and chronic obstructive pulmonary disease.
Kither Biotech
This company develops inhaled therapies for patients with respiratory diseases such as chronic obstructive pulmonary disease and cystic fibrosis.
Nebu-Flow
The company develops nebuliser technology for pharmaceutical partners to deliver biologic drugs and other formulations to the lungs of patients with respiratory disorders.
Respira
This biopharmaceutical company develops inhaled drug-device therapies for patients with cardiopulmonary diseases such as pulmonary hypertension and interstitial lung disease.
